Reply to Suman Sahoo, Abhishek Pandy, Swarnendu Mandal, Manoj Kumar Das, and Prasant Nayak's Letter to the Editor re: Wei Shen Tan, Aaron Pendergast, Charlotte Ackerman, et al. Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo. 2022.08.003

被引:0
作者
Tan, Wei Shen [1 ,2 ,5 ]
Mustard, Connor [3 ]
Kelly, John D. [1 ,4 ]
机构
[1] UCL, Div Surg & Intervent Sci, London, England
[2] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX USA
[3] Queen Mary Univ London, Barts Canc Inst, Ctr Expt Canc Med, London, England
[4] Univ Coll London Hosp, Dept Urol, London, England
[5] UCL, Div Surg & Intervent Sci, 43-45 Foley St, London W1W 7TY, England
关键词
GUIDELINES; MANAGEMENT;
D O I
10.1016/j.eururo.2022.11.006
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E48 / E49
页数:2
相关论文
共 10 条
  • [1] Methods to improve efficacy of intravesical mitomycin C: Results of a randomized phase III trial
    Au, JLS
    Badalament, RA
    Wientjes, MG
    Young, DC
    Warner, JA
    Venema, PL
    Pollifrone, DL
    Harbrecht, JD
    Chin, JL
    Lerner, SP
    Miles, BJ
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (08) : 597 - 604
  • [2] EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
    Babjuk, Marko
    Burger, Maximilian
    Zigeuner, Richard
    Shariat, Shahrokh F.
    van Rhijn, Bas W. G.
    Comperat, Eva
    Sylvester, Richard J.
    Kaasinen, Eero
    Boehle, Andreas
    Palou Redorta, Joan
    Roupret, Morgan
    [J]. EUROPEAN UROLOGY, 2013, 64 (04) : 639 - 653
  • [3] All High-Grade Ta Tumors Should be Classified as High Risk: Bacillus Calmette-Guerin Response in High-Grade Ta Tumors
    Bree, Kelly K.
    Hensley, Patrick J.
    Lobo, Niyati
    Brooks, Nathan A.
    Nogueras-Gonzalez, Graciela M.
    Guo, Charles C.
    Navai, Neema
    Grossman, H. Barton
    Dinney, Colin P.
    Kamat, Ashish M.
    [J]. JOURNAL OF UROLOGY, 2022, 208 (02) : 284 - +
  • [4] National Institute for Health and Care Excellence, 2015, Bladder cancer: Diagnosis and management
  • [5] Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group
    Tan, Wei Shen
    Steinberg, Gary
    Witjes, J. Alfred
    Li, Roger
    Shariat, Shahrokh F.
    Roupret, Morgan
    Babjuk, Marko
    Bivalacqua, Trinity J.
    Psutka, Sarah P.
    Williams, Stephen B.
    Cookson, Michael S.
    Palou, Juan
    Kamat, Ashish M.
    [J]. EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (05): : 505 - 516
  • [6] Re: Wei Shen Tan, Aaron Prendergast, Charlotte Ackerman, et al. Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial. Eur Urol. In press.
    Sahoo, Suman
    Pandey, Abhishek
    Mandal, Swarnendu
    Das, Manoj Kumar
    Nayak, Prasant
    [J]. EUROPEAN UROLOGY, 2023, 83 (02) : E47 - E47
  • [7] Intravesical device-assisted therapies for non-muscle-invasive bladder cancer
    Tan, Wei Shen
    Kelly, John D.
    [J]. NATURE REVIEWS UROLOGY, 2018, 15 (11) : 667 - 685
  • [8] Novel urinary biomarkers for the detection of bladder cancer: A systematic review
    Tan, Wei Shen
    Tan, Wei Phin
    Tan, Mae-Yen
    Khetrapal, Pramit
    Dong, Liqin
    deWinter, Patricia
    Feber, Andrew
    Kelly, John D.
    [J]. CANCER TREATMENT REVIEWS, 2018, 69 : 39 - 52
  • [9] Can Renal and Bladder Ultrasound Replace Computerized Tomography Urogram in Patients Investigated for Microscopic Hematuria?
    Tan, Wei Shen
    Sarpong, Rachael
    Khetrapal, Pramit
    Rodney, Simon
    Mostafid, Hugh
    Cresswell, Joanne
    Hicks, James
    Rane, Abhay
    Henderson, Alastair
    Watson, Dawn
    Cherian, Jacob
    Williams, Norman
    Brew-Graves, Chris
    Feber, Andrew
    Kelly, John D.
    [J]. JOURNAL OF UROLOGY, 2018, 200 (05) : 973 - 979
  • [10] Management of non-muscle invasive bladder cancer: A comprehensive analysis of guidelines from the United States, Europe and Asia
    Tan, Wei Shen
    Rodney, Simon
    Lamb, Benjamin
    Feneley, Mark
    Kelly, John
    [J]. CANCER TREATMENT REVIEWS, 2016, 47 : 22 - 31